Global Foot and Mouth Disease Vaccines Market is valued at USD 2.23 Billion in 2021 and expected to reach USD 4.19 Billion by 2028 with a CAGR of 9.4% over the forecast period.
Global Foot and Mouth Disease Vaccines Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2022-2028- Increasing prevalence of foot and mouth diseases, rising number of veterinary centres, and a growing number of government awareness programs for protecting animals are major factors anticipated to drive the global foot and mouth disease vaccines market.
Foot-and-mouth disease (FMD) is an extremely infectious disease of cloven-hoofed animals. The major areas of the world are affected by foot and disease mostly farmed cattle and swine, even though sheep, goats, and many wild species are also susceptible. Hoofed animals such as cows, pigs, sheep and goats are also affected by the virus. Blisters on feet and mouth caused by the virus also reduced milk production, lack of appetite, fever show animals suffering from the disease. The FMD virus (FMDV), is a highly variable RNA virus occurring in seven different strains A, O, C, Asia 1, Sat 1, Sat 2, and Sat 3 and a large number of subtypes. The foot and mouth disease vaccines address not only the need for FMD-free countries but also for the extermination of this distressing disease.
The FMD vaccine is molecular-based, which means it was designed utilizing a cell line fit for creating antigens (substances that incite immune reactions) without the utilization of the profoundly infectious FMD infection. Since the vaccine is created without utilizing live or killed FMD infection materials, it tends to be delivered securely and cost adequately in the U.S. central area and all over the planet. Field testing demonstrated that the vaccine can be securely controlled to dairy cattle under ordinary U.S. dairy cattle production conditions. The Plum Island Animal Disease Center (PIADC) created a vaccine for cows against FMD. The first of its sort in the United States, the FMD vaccine can be made on the U.S. mainland. A worldwide advantage of the vaccine is that inoculated animals can be effectively recognized from those presented to the illness.
The Covid-19 pandemic has also impacted the growth of the global foot and mouth vaccines market. The lockdown was imposed because the outbreak of COVID-19 caused supply chain disruptions of raw materials which caused a shortage of foot and mouth disease vaccines. The traveling restrictions due to lockdown have also negatively impacted the global foot and mouth disease vaccines market growth.
The global foot and mouth disease vaccines market is segmented into on the basis of animal type, vaccine type, distribution channel and region & country level. On the basis of animal type, the global foot and mouth disease vaccines market is segmented into cattle, pig, sheep and goat and others. On the basis of vaccine type, the market was segmented into conventional vaccines, oil-based vaccines, aluminum hydroxide/saponin-based vaccines and emergency vaccines. On the basis of distribution channels, the market was segmented into government organizations, distributors/ pharmacies, private vets and others.
The regions covered in global foot and mouth disease vaccines market report are North America, Europe, Asia-Pacific, Latin America and Rest of the World. On the basis of country level, the market of global foot and mouth disease vaccines is subdivided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, India, Japan, South East Asia, Middle East Asia (UAE, Egypt, Saudi Arabia) GCC, Africa, etc.
On December 18th, 2021; the Major and furthermost advanced production line of foot-and-mouth disease (FMD) vaccine in the country started operation in Alborz province on Saturday. With an annual production capacity of 20 million doses, the production line was set up in less than 10 months. The production of this vaccine will avoid the outflow of $30 million yearly, and with the achievement of its capacity, and will carry the country $20 million of foreign exchange per annum. In order to employ the FMD vaccine production site, 38 organizations cooperated and with its full operation, 80 staff of biotechnology field will be recruited. Foot-and-mouth disease or hoof-and-mouth disease is a communicable and sometimes fatal viral disease that affects cloven-hoofed animals, including domestic and wild bovids.
One of the major factors driving the growth of global foot and mouth diseases is increasing prevalence of foot and mouth disease. The foot and mouth disease are epidemics in some regions. FMD is a transmittable disease and countries in disease is epidemic cannot sale their animal origin products. FMD vaccine has been used to control a disease in epidemic countries. For instance; in January 2021, according to the USDA (United States Department of Agriculture) 93.6 million head of cattle and 7.75 million head of sheep and goats and 74.8 million head of swine as of March 2021 means nearly 200 million livestock animals that could be susceptible in the case of an FMD outbreak. In addition, rising number of veterinary centers is also supplementing the market growth. FMD is a highly spreadable and vulnerable disease of cloven-hoofed animals. Thus, it is one of the main animal health concerns for veterinary centers and serious risk to farmers, livestock industries and governments. Vaccination programs by veterinary center carried out to stop its further spread. For example; as per the news published on June 11th, 2021, virtual vaccine tabletop exercise launched by Institute for Infectious Animal Diseases (IIAD), a unit of Texas A&M AgriLife, and the Texas A&M College of Veterinary Medicine and Biomedical Sciences (CVMBS).
Moreover, growing government awareness programs are also fostering the market growth. The government is taking initiatives to make farmers aware regarding the benefits of vaccination against FMD as outbreak of results in important economic losses for farmers. Thus, World Organization for Animal Health (OIE) prioritized the fight against this disease. For instance, on February 21st, 2017, three international agreements supporting the animal health and global trade signed by USDA (United States Department of Agriculture). These initiatives by government for supporting animal health further boosting the growth of the foot and mouth disease vaccines market.
However, lack of awareness about vaccination especially underdeveloped economies may hamper the global foot and mouth disease vaccines market growth. In spite of that, increasing research & development activities in this field can provide various opportunities for the further growth of the global foot and mouth disease vaccines market.
Asia Pacific is expected to be the fastest-growing region in the global foot and mouth disease vaccines market due to the increasing number of FMD endemic countries, growing government initiatives for controlling the FMD virus and rising population in this region. For instance; Asia Pacific’s major areas are endemic region for foot and mouth disease such as Southeast Asia (SEA) and it was foremost animal health problem within the region. Thus, need of animal vaccination driving the growth of the market in this region. In addition to that, supportive initiatives taken by government for targeting disease and eradication of FMD virus through vaccination are also adding growth to the market. For example; on March 3rd, 2018; a joint venture launched by three leading animal health companies targeting foot-and-mouth disease in China. Additionally, in September 2019, Prime Minister Narendra Modi launched National Animal Disease Control Programme (NADCP) a flagship scheme for control of Foot & Mouth Disease and Brucellosis by vaccinating 100% cattle, buffalo, sheep, goat and pig population for FMD and 100% bovine female calves of 4-8 months of age for brucellosis with the total expenditure of Rs.13, 343.00 crore for next five years.
North America is expected as a largest market for the global foot and mouth disease vaccines market due to the early adoption of vaccines and government support for vaccination in animals in this region. For instance; in October 22nd, 2020; FMD vaccine bank requested in Canada because of the outbreak in Canada, the United States and Mexico established the North American foot-and-mouth vaccine bank with help of this bank more number of FMD vaccines can be stored for vaccinations.
|Historical data||2015 - 2020|
|Forecast Period||2021 - 2028|
|Market Size in 2021:||USD 2.23 Billion|
|Base year considered||2020|
|Forecast Period CAGR %:||
|Market Size Expected in 2028:||USD 4.19 Billion|
|Tables, Charts & Figures:||175|
|Foot and Mouth Disease Vaccine Manufacturers||Merck & Co. Inc., Agrovet Co., Boehringer Ingelheim International GmbH, FGBI - Federal Centre for Animal Health, Merial (France), FMD Center, Veterinary Serum and Vaccine Research Institute, Biogénesis Bago, Indian Immunologicals Limited, Agrovet Co, Limor de Colombia, others|
|Segments Covered||By Animal Type, By Vaccine Type, By Distribution Channel|
|Regional Analysis||North America, U.S., Mexico, Canada, Europe, UK, France, Germany, Italy, Asia Pacific, China, Japan, India, Southeast Asia, South America, Brazil, Argentina, Columbia, The Middle East and Africa, GCC, Africa, Rest of the Middle East and Africa|